Arkolith/Insider Trading/JAZZ/Form 4

Mulligan Seamus

DirectorJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Jun 1, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2026Option exercise(M)3K$138.08$472K1.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2026Option exercise(M)3K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001536639-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML